| 000 | 01683nam a2200421 i 4500 | ||
|---|---|---|---|
| 001 | ocn962069481 | ||
| 003 | OCoLC | ||
| 005 | 20170826160832.0 | ||
| 006 | m o d f | ||
| 007 | cr mn||||||||| | ||
| 008 | 161104s2011 dcu ob f000 0 eng c | ||
| 040 |
_aGPO _beng _erda _epn _cGPO _dGPO |
||
| 042 | _apcc | ||
| 043 | _an-us--- | ||
| 074 | _a0445-B-07 (online) | ||
| 086 | 0 | _aHE 1.75:OEI-07-08-00152 | |
| 088 | _aOEI-07-08-00152 | ||
| 099 | _aHE 1.75:OEI-07-08-00152 | ||
| 110 | 1 |
_aUnited States. _bDepartment of Health and Human Services. _bOffice of Inspector General, _eauthor. |
|
| 245 | 1 | 0 |
_aMemorandum report : _bensuring that Medicare Part D reimbursement is limited to drugs provided for medically accepted indications. |
| 246 | 3 | 0 | _aEnsuring that Medicare Part D reimbursement is limited to drugs provided medically accepted indications |
| 246 | 1 |
_iRunning title: _aMedically accepted indications for Part D drugs |
|
| 264 | 1 |
_aWashington, D.C. : _bDepartment of Health and Human Services, Office of Inspector General, _c2011. |
|
| 300 | _a1 online resource (9 pages) | ||
| 337 | _2rdamedia | ||
| 338 | _2rdacarrier | ||
| 588 | _aDescription based on online resource; title from PDF title page (HHS, viewed Nov. 3, 2016). | ||
| 500 | _a"Nov[ember] 14 2011." | ||
| 500 | _a"OEI-07-08-00152." | ||
| 500 | _aCRDP Project record. | ||
| 504 | _aIncludes bibliographical references. | ||
| 650 | 0 | _aMedicare. | |
| 650 | 0 |
_aPharmaceutical services insurance _zUnited States. |
|
| 650 | 0 |
_aDrugs _xPrescribing _zUnited States. |
|
| 856 | 4 | 0 | _uhttp://purl.fdlp.gov/GPO/gpo74122 |
| 949 |
_aBEV _bFed Docs |
||
| 942 | _c3 | ||
| 999 |
_c265485 _d265485 |
||